Make an accurate and fast diagnosis of melanoma and other skin lesions with state-of-the-art medical technology from Speclipse. Order your Spectra-Scope skin cancer detection devices now!
If you want a user-friendly, cutting-edge tech device to swiftly and accurately diagnose early-stage skin cancer without resorting to biopsies, check out the Spectra-Scope from Speclipse today!
Whether you're a doctor, nurse, or support technician, the advanced skin-scanning device can facilitate the early detection and diagnosis of conditions such as melanoma and squamous cell carcinoma.
Catch cancer early while saving money on biopsy procedures with the Spectra-Scope from Speclipse. More details here: https://www.speclipse.com
The newly updated Spectra-Scope provides you with a swift and effective diagnostic alternative to the traditionally drawn-out procedures for identifying cancers of the skin.
Statistics show that skin cancer is one of the most prevalent forms of cancer in the United States. According to the American Academy of Dermatology, around 9,500 people nationwide are diagnosed with skin cancer every day.
By harnessing the power of laser-induced plasma spectroscopy, the Spectra-Scope can analyze biochemical information contained in skin tissue at both a molecular and atomic level. You're able to make a fast and accurate oncological diagnosis through the device's AI-based algorithm.
The device offers you near-instantaneous secondary verification, enabling better clinical decision-making and recommendations. Lesions identified using the Spectra-Scope have a much higher chance of positive diagnosis in later biopsies.
Scanning takes a matter of seconds to complete, saving you valuable time amid your busy schedule and patient demands. Time is also of the essence in regards to effective cancer treatment, as early detection can be the difference between complete remission and a life-threatening condition.
The Spectra-Scope's diagnostic algorithm, which has a total of 5302 emission spectra, can accurately differentiate between BCC, SCC, and malignant melanoma.
Clinical studies have revealed the device to have 97% accuracy and 86% specificity in the identification of malignant and benign lesions, proving both its effectiveness and safety for diagnostic care.
Diagnostic results generated by the Spectra-Scope give a LIPS score along with the corresponding Negative and Positive Predictive Value. Previous assessments are also stored within the unit, allowing you to quickly access relevant clinical history of lesions.
Speclipse was founded by a leading dermatologist and a group of Stanford University graduates. The team is committed to harnessing cutting-edge AI and laser technology in the treatment of skin cancer, providing advanced and cost-effective diagnostic tools.
A spokesperson says, “Over-diagnosis of skin cancer is a common first-world problem. The good news is Spectra-Scope skin cancer detection machine can help stop it.”
With the launch of its updated device, Speclipse continues to make advanced cancer diagnostics accessible to medical and non-medical professionals nationwide.
If you want to save your clinic and patients money while also saving lives, order your Spectra-Scope today!
Go to https://www.speclipse.com so you can learn more!
